Intraocular pressure-regulated early genes and uses thereof
AssigneeMcGill University
InventorH. Uri Saragovi
Life of this patent
Estimating the term…
Loading patent…
AssigneeMcGill University
InventorH. Uri Saragovi
Estimating the term…
The present invention relates to methods to treat glaucoma and glaucoma-related conditions through the regulation of changes in gene expression that are mediated by high intraocular pressure or α2 macgroglobulin administration. Glaucoma, retinal ganglion cell (RGC) death and chronic ocular hypertension are treated using pharmaceutical compositions which comprise substances that inhibit the expression or activity of intraocular pressure-regulated early genes (IPREGs) or their gene products that are up-regulated by high intraocular pressure or α2 macgroglobulin administration and/or which increase the expression or activity of IPREGs or their gene products that are down-regulated by high intraocular pressure or α2 macgroglobulin administration. The invention also relates to methods of identifying an IPREG and methods to test for chronic ocular degeneration and the onset of RGC stress in an individual by measuring the expression level of IPREG proteins.
A method of treating glaucoma in a mammal in need thereof comprising administering to the mammal an effective amount of a composition that inhibits the expression or activity of α2 macroglobulin.
(canceled)
(canceled)
10-16. (canceled)
A method of preventing retinal ganglion cell (RGC) death mediated by high intraocular pressure (IOP) comprising administering to an individual in need thereof an effective amount of a composition that inhibits the expression or activity of α2 macroglobulin.
A method of preventing chronic ocular degeneration in a mammal in need thereof comprising administering to the mammal an effective amount of a composition that inhibits the expression or activity of α2 macroglobulin.
A method of testing for chronic ocular degeneration in a patient comprising:
A method of testing for the onset of RGC stress in a patient comprising:
A method of identifying an intraocular pressure-regulated early gene (IRPEG) comprising:
-35. (canceled)
Dependencies are inferred from the claim text.